Eli Lilly and Company today announced the promotion of Aarti Shah, Ph.D., to senior vice president and chief information officer effective July 1. She has been the global brand development leader for immunology since 2013.
Shah joined Lilly in 1994 as a senior statistician after completing her doctorate in applied statistics from the University of California, Riverside. During her career at Lilly, she has held many technical and administrative leadership positions, both in the United States and abroad, including serving as vice president for biometrics and advanced analytics and as executive director of global information sciences.
In her new role, she will lead the efforts of a worldwide IT organization with more than 1,300 employees, in addition to many contractors and external business partners, to deliver innovative IT solutions to the business. She will report to Derica Rice, Lilly’s executive vice president of Global Services and chief financial officer.
“As a visionary and inspirational leader, Aarti has a proven track record of building strong, flexible and sustainable organizations. She is known for her relentless focus and passion for developing people. And her deep knowledge of drug development will be vital as IT touches every aspect of our business,” Rice said.
“I want to create an environment in which IT enables and brings innovative solutions to business transformations across Lilly’s entire drug development value chain from discovery to commercial. I hope to do this by unleashing the potential of our employees and by building strong internal and external collaborations and thus play a critical role in bringing Lilly’s mission to life,” Shah said.
Shah serves on the board of directors for the Indianapolis Public Library Foundation and Center for Interfaith Cooperation and on the Executive Advisory Council for the Healthcare Businesswoman’s Association (HBA) Indiana Chapter. She received the 2011 Rising Star Award from Healthcare Businesswoman’s Association (HBA).
Source: Eli Lilly and Company
According to a study conducted by the company that included more than 600 participants, samples collected with the Teal Wand were shown to be just as accurate as those taken by a clinician during an office visit. About 94% of participants said they would opt for self-collection in the future, and 86% said they felt they would be more likely to stay up to date with cervical cancer screening if they could do it at home.
Jeremy Walsh was named head of IT and AI, according to his post on LinkedIn. The move was first reported by Politico. Walsh previously held the role of chief technologist at Booz Allen Hamilton, managing AI- and cloud-based projects for 14 years at the consultancy.
The new organization features two Business Groups that will rely on dedicated teams and assets to fully focus on meeting customer and market needs. Isabelle Bouvier is appointed as CEO of the Health & Pharma Solutions Business Group and Pascal Leroy as CEO of the Nutrition & Bioindustry Business Group. Béatrice Totel replaces Isabelle Bouvier as CFO of Roquette.
